Columbia Wanger Asset Management’s Agios Pharmaceuticals AGIO Stock Holding History

Columbia Wanger Asset Management’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$43.5M	Sell	760,116 -129,026	-15%	-$8.12M	0.65%	55
2017 Q3	$59.4M	Buy	889,142 +120,200	+16%	+$7.22M	0.88%	27
2017 Q2	$39.6M	Buy	768,942 +158,856	+26%	+$8.12M	0.56%	68
2017 Q1	$35.6M	Sell	610,086 -26,204	-4%	-$1.26M	0.5%	95
2016 Q4	$26.6M	Buy	636,290 +10,663	+2%	+$560K	0.37%	121
2016 Q3	$33M	Buy	625,627 +226,391	+57%	+$9.86M	0.43%	105
2016 Q2	$16.7M	Sell	399,236 -27,724	-6%	-$1.37M	0.19%	151
2016 Q1	$17.3M	Sell	426,960 -10,034	-2%	-$429K	0.19%	145
2015 Q4	$28.4M	Buy	436,994 +44,861	+11%	+$2.94M	0.28%	128
2015 Q3	$27.7M	Sell	392,133 -84,471	-18%	-$8.26M	0.22%	147
2015 Q2	$53M	Buy	476,604 +131,604	+38%	+$14.2M	0.34%	112
2015 Q1	$32.5M	Buy	+345,000	New	+$38.7M	0.18%	175

Other funds holding AGIO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Columbia Wanger Asset Management's AGIO Position: Q4 2017 in Review

Columbia Wanger Asset Management reduced its Agios Pharmaceuticals (AGIO) stake by 15% in Q4 2017, selling an estimated $8.12M and leaving 760,116 shares worth $43.5M. The position accounts for 0.65% of the portfolio, ranked #55.

Columbia Wanger Asset Management first reported a position in AGIO in Q1 2015 and has held it in 12 quarters since. The position peaked at $59.4M in Q3 2017. 178 funds tracked by Wall St. Rank hold AGIO as of Q4 2017.

Columbia Wanger Asset Management held 760,116 shares of Agios Pharmaceuticals worth $43.5M as of Q4 2017.
Columbia Wanger Asset Management sold 129,026 Agios Pharmaceuticals shares in Q4 2017, an estimated $8.12M.
Agios Pharmaceuticals made up 0.65% of Columbia Wanger Asset Management's portfolio in Q4 2017, its #55 holding.
Columbia Wanger Asset Management first reported a position in Agios Pharmaceuticals in Q1 2015 and has held it in 12 quarters since.
Columbia Wanger Asset Management's Agios Pharmaceuticals position peaked at $59.4M in Q3 2017.
178 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2017.

Based on Columbia Wanger Asset Management's 13F filing for Q4 2017, filed 13 Feb 2018.